What is Idexx Laboratories Inc's Market Cap?

Idexx Laboratories Inc's Market Cap is $41.0B, based on as-reported figures from SEC (XBRL) filings.

What is Idexx Laboratories Inc's Enterprise Value?

Idexx Laboratories Inc's Enterprise Value is $41.2B, based on as-reported figures from SEC (XBRL) filings.

What is Idexx Laboratories Inc's Trailing P/E?

Idexx Laboratories Inc's Trailing P/E is 36.0×, based on as-reported figures from SEC (XBRL) filings.

What is Idexx Laboratories Inc's Price / Sales?

Idexx Laboratories Inc's Price / Sales is 9.0×, based on as-reported figures from SEC (XBRL) filings.

What is Idexx Laboratories Inc's EV / Revenue?

Idexx Laboratories Inc's EV / Revenue is 9.1×, based on as-reported figures from SEC (XBRL) filings.

What is Idexx Laboratories Inc's EV / EBITDA?

Idexx Laboratories Inc's EV / EBITDA is 26.3×, based on as-reported figures from SEC (XBRL) filings.

What is Idexx Laboratories Inc's Revenue (TTM)?

Idexx Laboratories Inc's Revenue (TTM) is $4.6B, based on as-reported figures from SEC (XBRL) filings.

What is Idexx Laboratories Inc's Net Income (TTM)?

Idexx Laboratories Inc's Net Income (TTM) is $1.1B, based on as-reported figures from SEC (XBRL) filings.

What is Idexx Laboratories Inc's EBITDA?

Idexx Laboratories Inc's EBITDA is $1.6B, based on as-reported figures from SEC (XBRL) filings.

What is Idexx Laboratories Inc's Diluted EPS (TTM)?

Idexx Laboratories Inc's Diluted EPS (TTM) is 14.47, based on as-reported figures from SEC (XBRL) filings.

Idexx Laboratories Inc (IDXX) Financial Statements

Idexx Laboratories Inc

SIC 2835 · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

FIGI BBG001S5S4Y9

XNAS · usd

520.21▼ 15.17 (-2.83%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close535.38

Day's Range519.07 – 529.02

52-Week Range518.55 – 769.98

Volume610.8K

Avg Volume565.8K

Share Statistics

Shares Outstanding

Employees11.0K

ExchangeXNAS

Listed1991-06-21

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Idexx Laboratories Inc (IDXX)

What is Idexx Laboratories Inc's Market Cap?: Idexx Laboratories Inc's Market Cap is $41.0B, based on as-reported figures from SEC (XBRL) filings.
What is Idexx Laboratories Inc's Enterprise Value?: Idexx Laboratories Inc's Enterprise Value is $41.2B, based on as-reported figures from SEC (XBRL) filings.
What is Idexx Laboratories Inc's Trailing P/E?: Idexx Laboratories Inc's Trailing P/E is 36.0×, based on as-reported figures from SEC (XBRL) filings.
What is Idexx Laboratories Inc's Price / Sales?: Idexx Laboratories Inc's Price / Sales is 9.0×, based on as-reported figures from SEC (XBRL) filings.
What is Idexx Laboratories Inc's EV / Revenue?: Idexx Laboratories Inc's EV / Revenue is 9.1×, based on as-reported figures from SEC (XBRL) filings.
What is Idexx Laboratories Inc's EV / EBITDA?: Idexx Laboratories Inc's EV / EBITDA is 26.3×, based on as-reported figures from SEC (XBRL) filings.
What is Idexx Laboratories Inc's Revenue (TTM)?: Idexx Laboratories Inc's Revenue (TTM) is $4.6B, based on as-reported figures from SEC (XBRL) filings.
What is Idexx Laboratories Inc's Net Income (TTM)?: Idexx Laboratories Inc's Net Income (TTM) is $1.1B, based on as-reported figures from SEC (XBRL) filings.
What is Idexx Laboratories Inc's EBITDA?: Idexx Laboratories Inc's EBITDA is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is Idexx Laboratories Inc's Diluted EPS (TTM)?: Idexx Laboratories Inc's Diluted EPS (TTM) is 14.47, based on as-reported figures from SEC (XBRL) filings.